厄贝沙坦片与硝苯地平缓释片联合治疗高血压合并冠心病的 临床疗效观察
摘要
关键词
全文:
PDF参考
[1]SAMUEL TAN,WENCHY SIU,SHASAWAT KUMAR,et al.Abstract 11840:Outcomes and Disparities of Asian Patients With Severe
Chronic Kidney Disease Admitted for Heart Failure[J].Circulation,2023,148(Suppl_1):A11840-A11840.
[2]ZHALEH ATAEI,SERGIO RUIZ-CARMONA,LEAH WRIGHT,et al.Abstract 18857:Association Between Physical Activity and
Risk of Incident Cardiovascular Disease in Women With Novel Risk Factors:Evidence From the UK Biobank Cohort[J].Circulation,
2023,148(Suppl_1):A18857-A18857.
[3]种小娟,姬劲锐.高血压并冠心病应用厄贝沙坦治疗的效果及对患者血管内皮功能与炎性因子的影响[J].罕少疾病杂志,
2023,30(5):44-45,56.
[4]HIROKAZU,SHIMONO,AKIHIRO,TOKUSHIGE,DAISUKE,KANDA,et al.Association of preoperative clinical frailty and clinical
outcomes in elderly patients with stable coronary artery disease after percutaneous coronary intervention[J].Heart and vessels:An
international journal,2023,38(10):1205-1217.
[5]TIANLONG LI,CHEN WANG,LI MA.Analysis of Clinical Characteristics and Influencing Factors for H-Type Hypertension
Complicated with Other Chronic Diseases in a Community in Beijing[J].Evidence-based complementary and alternative medicine:
eCAM,2022,2022(Pt.30):ArticleID6974065.
[6]LEI YU,JIANBIN SUN,XINGUANG LIU.A retrospective study of the association between serum uric acid and risk of coronary heart
disease complicated with different types of chronic heart failure[J].European Journal of Medical Research,2025,30(1).
[7]林冰君.清眩降压汤辅助厄贝沙坦片治疗原发性高血压合并冠心病的疗效及对24 h动态血压监测结果的影响[J].心血管病防
治知识,2023,13(15):27-30.
[8]羊倩倩.PAS 疗法联合厄贝沙坦对冠心病合并高血压病人 Salusin-β、Apelin 水平的影响[J].中西医结合心脑血管病杂志,
2022,20(8):1483-1485.
[9]李秋兰,杨丽萍.厄贝沙坦对高血压合并冠心病血管内皮功能和炎性因子的影响[J].心血管病防治知识,2022,12(17):14-16.
[10]周宇飞,罗钢,毛琳慎,等.厄贝沙坦治疗高血压合并冠心病的疗效及对患者血管内皮功能的影响[J].当代医药论丛,2022,
20(18):138-141.
[11]刘杰妮.阿司匹林联合厄贝沙坦治疗高血压合并冠心病患者的临床疗效[J].临床合理用药杂志,2022,15(9):49-51.
(3 摘要 Views, 0 PDF Downloads)
Refbacks
- 当前没有refback。